Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

238 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Patterns and predictors of multiple sclerosis phenotype transition.
Pontieri L, Greene N, Wandall-Holm MF, Geertsen SS, Asgari N, Jensen HB, Illes Z, Schäfer J, Jensen RM, Sejbæk T, Weglewski A, Mahler MR, Poulsen MB, Prakash S, Stilund M, Kant M, Rasmussen PV, Svendsen KB, Sellebjerg F, Magyari M. Pontieri L, et al. Among authors: illes z. Brain Commun. 2024 Nov 23;6(6):fcae422. doi: 10.1093/braincomms/fcae422. eCollection 2024. Brain Commun. 2024. PMID: 39713244 Free PMC article.
Risk of hypertension in patients with multiple sclerosis treated with teriflunomide compared to dimethyl fumarate: A nationwide cohort study in Denmark.
Framke E, Sellebjerg F, Kant M, Stilund M, Jensen HB, Illes Z, Asgari N, Sejbaek T, Roug LC, Jensen MB, Schäfer J, Rasmussen PV, Christensen JR, Weglewski A, Prakash S, Magyari M; DMSG study group*. Framke E, et al. Among authors: illes z. Mult Scler. 2024 Dec 4:13524585241299715. doi: 10.1177/13524585241299715. Online ahead of print. Mult Scler. 2024. PMID: 39632560
Smouldering-Associated Worsening in Multiple Sclerosis: An International Consensus Statement on Definition, Biology, Clinical Implications, and Future Directions.
Scalfari A, Traboulsee A, Oh J, Airas L, Bittner S, Calabrese M, Garcia Dominguez JM, Granziera C, Greenberg B, Hellwig K, Illes Z, Lycke J, Popescu V, Bagnato F, Giovannoni G. Scalfari A, et al. Among authors: illes z. Ann Neurol. 2024 Nov;96(5):826-845. doi: 10.1002/ana.27034. Epub 2024 Jul 25. Ann Neurol. 2024. PMID: 39051525 Review.
Pseudomonas aeruginosa infection correlates with high MFI donor-specific antibody development following lung transplantation with consequential graft loss and shortened CLAD-free survival.
Bogyó LZ, Török K, Illés Z, Szilvási A, Székely B, Bohács A, Pipek O, Madurka I, Megyesfalvi Z, Rényi-Vámos F, Döme B, Bogos K, Gieszer B, Bakos E. Bogyó LZ, et al. Among authors: illes z. Respir Res. 2024 Jul 1;25(1):262. doi: 10.1186/s12931-024-02868-1. Respir Res. 2024. PMID: 38951782 Free PMC article.
Extended interval dosing with ocrelizumab in multiple sclerosis.
Novak F, Bajwa HM, Østergaard K, Berg JM, Madsen JS, Olsen DA, Urbonaviciute I, Illes Z, Stilund ML, Romme Christensen J, Bramow S, Sellebjerg F, Sejbaek T. Novak F, et al. Among authors: illes z. Mult Scler. 2024 Jun;30(7):847-856. doi: 10.1177/13524585241245296. Epub 2024 Apr 22. Mult Scler. 2024. PMID: 38646949
Prognostic factors for disease activity in newly diagnosed teriflunomide-treated patients with multiple sclerosis: a nationwide Danish study.
Mahler MR, Magyari M, Pontieri L, Elberling F, Holm RP, Weglewski A, Poulsen MB, Storr LK, Bekyarov PA, Illes Z, Kant M, Sejbaek T, Stilund ML, Rasmussen PV, Brask M, Urbonaviciute I, Sellebjerg F. Mahler MR, et al. Among authors: illes z. J Neurol Neurosurg Psychiatry. 2024 Sep 17;95(10):979-987. doi: 10.1136/jnnp-2023-333265. J Neurol Neurosurg Psychiatry. 2024. PMID: 38569873
238 results